Quantifying F2-isoprostanes in umbilical cord blood of newborn by gas chromatography-mass spectrometry

Analytical Biochemistry

Volumn 316, Issue 1, 2003, Pages 111-117

  Chu, Kai On ^a   Wang, Chi Chiu ^a   Rogers, Michael Scott ^a   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

8 Iso prostaglandin F2 ; Cord blood; F2 isoprostanes; GC MS

Indexed keywords

AMMONIA; BLOOD; BROMINE COMPOUNDS; EXTRACTION; MASS SPECTROMETRY; PHASE SEPARATION;

CORD BLOOD; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GC/MS; INTRA-ASSAY PRECISION; ISOPROSTANES; LIMIT OF QUANTITATIONS; METHOD DETECTION LIMITS; SOLID-PHASE EXTRACTION COLUMNS;

GAS CHROMATOGRAPHY;

8 ISOPROSTAGLANDIN F2 ALPHA; AMMONIA; CITRIC ACID; CYCLOHEXANE; ISOPROSTANE DERIVATIVE; METHANOL;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERIVATIZATION; ELUTION; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; INTERMETHOD COMPARISON; MASS SPECTROMETRY; NEWBORN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; UMBILICAL CORD BLOOD; BLOOD; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FETUS BLOOD; MASS FRAGMENTOGRAPHY; METHODOLOGY; PREGNANCY; TIME;

F2-ISOPROSTANES; FEMALE; FETAL BLOOD; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT, NEWBORN; PREGNANCY; TIME FACTORS;

EID: 0037403183     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(03)00043-5     Document Type: Article

References (31)

1. Morrow J.D., Harris T.M., Roberts II L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1990;1-10.
2. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., Roberts II L.J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:1992;10721-10725.
3. Morrow J.D., Awad J.A., Kato T., Takahashi K., Badr K.F., Roberts II L.J., Burk R.F. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90:1992;2502-2507.
4. Morrow J.D., Roberts II L.J. Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol. 233:1994;163-174.
5. Stein C.M., Tanner S.B., Awad J.A., Roberts II L.J., Morrow J.D. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 39:1996;1146-1150.
6. Takahashi K., Nammour T.M., Fukunaga M., Ebert J., Morrow J.D., Roberts II L.J., Hoover R.L., Badr K.F. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J. Clin. Invest. 90:1992;136-141.
7. Mathews W.R., Guido D.M., Fisher M.A., Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Radicals Biol. Med. 16:1994;763-770.
8. Doll R., Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J. Epidemiol. Community Health. 32:1978;303-313.
9. Kannel W.B. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101:1981;319-328.
10. Yang Z.P., Morrow J.D., Wu A., Roberts II L.J., Dettbarn W.D. Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo. Biochem. Pharmacol. 52:1996;357-361.
11. Rogers M.S., Wang W., Mongelli M., Pang C.P., Duley J.A., Chang A.M. Lipid peroxidation in cord blood at birth: a marker of fetal hypoxia during labour. Gynecol. Obstet. Invest. 44:1997;229-233.
12. Russell G.A. Antioxidants and neonatal lung disease. Eur. J. Pediatr. 153(Suppl. 2):1994;S36-S41.
13. Gerber R.T., Holemans K., O'Brien-Coker I., Mallet A.I., van Bree R., Van Assche F.A., Poston L. Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidation. Am. J. Obstet. Gynecol. 183:2000;1035-1040.
14. McKinney E.T., Shouri R., Hunt R.S., Ahokas R.A., Sibai B.M. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am. J. Obstet. Gynecol. 183:2000;874-877.
15. Halliwell B., Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213:1987;9-14.
16. Longmire A.W., Swift L.L., Roberts II L.J., Awad J.A., Burk R.F., Morrow J.D. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem. Pharmacol. 47:1994;1173-1177.
17. Qin Y., Wang C.C., Kuhn H., Rathmann J., Pang C.P., Rogers M.S. Determinants of umbilical cord arterial 8-iso-prostaglandin F2alpha concentrations. Br. J. Obstet. Gynecol. 107:2000;973-981.
18. Morrow J.D., Minton T.A., Badr K.F., Roberts II L.J. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim. Biophys. Acta. 1210:1994;244-248.
19. Tsikas D., Schwedhelm E., Fauler J., Gutzki F.M., Mayatepek E., Frolich J.C. Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J. Chromatogr. B. 716:1998;7-17.
20. Schwedhelm E., Tsikas D., Durand T., Gutzki F.M., Guy A., Rossi J.C., Frolich J.C. Tandem mass spectrometric quantification of8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine. J. Chromatogr. B. 744:2000;99-112.
21. Ferretti A., Flanagan V.P. Isolation and measurement of urinary 8-iso-prostaglandin F2alpha by high-performance liquid chromatography and gas chromatography-mass spectrometry. J. Chromatogr. B. 694:1997;271-276.
22. Ohashi N., Yoshikawa M. Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B. 746:2000;17-24.
23. Hoffman S.W., Roof R.L., Stein D.G. A reliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2 alpha: a marker for lipid peroxidation after experimental brain injury. J. Neuro. Methods. 68:1996;133-136.
24. Morrow J.D., Zackert W.E., Yang J.P., Kurhts E.H., Callewaert D., Dworski R., Kanai K., Taber D., Moore K., Oates J.A., Roberts II L.J. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal. Biochem. 269:1999;326-331.
25. Morrow J.D., Roberts II L.J. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 300:1999;3-12.
26. Bessard J., Cracowski J.L., Stanke-Labesque F., Bessard G. Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J. Chromatogr. B. 754:2001;333-343.
27. Unregulated Contaminant Monitoring Regulation Analytical Method (UCMR), List 1 and List 2, EPA No. 815-R-00-006, Chemical Analytical Methods and Quality Control Manual, March 2000, United States Environmental Protection Agency, 1999.
28. Rogers M.S., Mongellia J.M., Tsang B., Wang C.C. Feto-maternal level of lipid peroxidation in term pregnancies. Acta Obstet. Gynecol. Scand. 78:1999;120-124.
29. Hübschmann H.J. Handbook of GCMS Fundamentals and Applications. 2001;513-519 Wiley-VCH, Weinheim.
30. Hübschmann H.J. Handbook of GCMS Fundamentals and Applications. 2001;148-157 Wiley-VCH, Weinheim.
31. Knighton W.B., Sears L.J., Grimsrud E.P. High pressure electron capture mass spectrometry. Mass Spectrometry Rev. 14:1995;327-343.